These findings suggest that TBG partially restores serotonergic receptor expression—particularly Htr2a—and attenuates lung cancer-induced neuroinflammation, as evidenced by reduced microglial activation and normalization of pro-inflammatory gene expression. This evidence concerns the gene HTR2A and lung carcinoma.